丁二磺酸腺苷蛋氨酸与地塞米松联合对妊娠期肝内胆汁淤积患者疗效观察及对患者炎症因子和肝功能影响

李珺

doi:10.3969/j.issn.1671-038X.2018.01.11

丁二磺酸腺苷蛋氨酸与地塞米松联合对妊娠期肝内胆汁淤积患者疗效观察及对患者炎症因子和肝功能影响

李珺^,

- 永康市第一人民医院产科, 浙江永康 321300

详细信息

通讯作者: 李珺,E-mail:175740502@qq.com

中图分类号: R575

收稿日期: 2017-09-10

Clinical efficacy of DL two sulfonic acid met methionine combined with dexamethasone in the treatment of intrahepatic cholestasis of pregnancy and its influence on inflammatory factors and liver function in patients with intrahepatic cholestasis of pregnan

LI Jun^,

- Department of Obstetrics, the First People's Hospital of Yongkang, Zhejiang, Yongkang 321300, China

More Information

Corresponding author: LI Jun, E-mail: 175740502@qq.com

Received Date: 10 September 2017

摘要

摘要: [目的]探讨妊娠期肝内胆汁淤积患者应用丁二磺酸腺苷蛋氨酸与地塞米松联合治疗疗效及对患者炎症因子和肝功能影响。[方法]选自我院于2015年3月~2017年3月收治的妊娠期肝内胆汁淤积患者98例, 按照随机表法分为观察组49例与对照组49例。对照组采用地塞米松治疗, 观察组在对照组基础上结合丁二磺酸腺苷蛋氨酸治疗。2组疗程均为7d。比较2组治疗疗效, 治疗前后瘙痒症状评分、炎症因子和肝功能指标变化, 及围产儿结局。[结果]观察组治疗总有效率 (93.88%) 高于对照组 (73.47%) (P＜0.05)。2组治疗后瘙痒症状评分降低 (观察组:t=38.0195, 对照组:t=20.9042, P＜0.05);观察组治疗后瘙痒症状评分低于对照组 (t=26.3529, P＜0.05)。2组治疗后IL-12降低而IL-4上升 (观察组:t=45.8014、13.1525, 对照组:t=24.3220、5.4033, P＜0.05);观察组治疗后IL-12低于对照组而IL-4高于对照组 (t=18.8016、7.3593, P＜0.05)。2组治疗后AST和ALT水平降低 (观察组:t=25.5940、24.4389, 对照组:t=11.8117、10.6163, P＜0.05);观察组治疗后AST和ALT水平低于对照组 (t=20.1611、20.2102, P＜0.05)。观察组新生儿窒息、胎儿窘迫和早产儿发生率低于对照组 (P＜0.05)。[结论]丁二磺酸腺苷蛋氨酸联合地塞米松治疗妊娠期肝内胆汁淤积患者临床疗效明显, 且能够减轻炎症反应及改善患者肝功能。
- 妊娠期肝内胆汁淤积 /
- 疗效 /
- 炎症因子 /
- 肝功能
Abstract: [Objective] To investigate the clinical efficacy of DL two sulfonic acid met methionine combined with dexamethasone in the treatment of intrahepatic cholestasis of pregnancy and its influence on inflammatory factors and liver function in patients with intrahepatic cholestasis of pregnancy.[Methods] 98 patients with intrahepatic cholestasis of pregnancy admitted to our hospital from March 2015 to March2017 were randomly divided into an observation group (49 cases) and a control group (49 cases).The control group was treated with dexamethasone, and the observation group was treated with DL two sulfonic acid met methionine on the basis of the control group.The two groups were treated with 7 d.The therapeutic effect, pruritus score, inflammatory factors and liver function indexes, and perinatal outcomes were compared between the two groups.[Results] the total effective rate of the observation group (93.88%) was higher than that of the control group (73.47%) (P＜0.05).The score of pruritus was lower in the two groups (observation group:t=38.0195, control group:t=20.9042, P＜0.05);the score of pruritus aftertreatment in the observation group was lower than that in the control group (t=26.3529, P＜0.05).The two groups after treatment decreased IL-12 and increased IL-4 (observation group:t=45.8014, 13.1525, the control group:t=24.3220, 5.4033, P＜0.05);the patients in the observation group than in the control group IL-12 and IL-4 was higher than the control group (t=18.8016, 7.3593, P＜0.05).AST and ALT levels decreased in two groups after treatment (observation group:t=25.5940, 24.4389, the control group:t=11.8117, 10.6163, P＜0.05);observation of AST and ALT levels after treatment were lower than those of the control group (t=20.1611, 20.2102, P＜0.05).The incidence of neonatal asphyxia, fetal distress and premature infants in the observation group was lower than that in the control group (P＜0.05).[Conclusion] DL two sulfonic acid met methionine combined with dexamethasone is effective in the treatment of intrahepatic cholestasis of pregnancy, and can improve inflammatory factors and liver function in patients with intrahepatic cholestasis.
- intrahepatic cholestasis of pregnancy /
- efficacy /
- inflammatory factors /
- liver function

HTML全文

参考文献(11)

[1]	Brouwers L, Koster M P, Page-Christiaens G C, et al.Intrahepatic cholestasis of pregnancy:maternal and fetal outcomes associated with elevated bile acid levels[J].American Journal of Obstetrics & Gynecology, 2015, 212 (1):1-7.
[2]	Puljic A, Kim E, Page J, et al.The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age.[J].American Journal of Obstetrics & Gynecology, 2015, 212 (5):1-5.
[3]	Kremer A E, Bolier R, Dixon P H, et al.Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy[J].Journal of Hepatology, 2015, 62 (4):897-904.
[4]	Abu-Hayyeh S, Ovadia C, Lieu T M, et al.Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum[J].Hepatology, 2016, 63 (4):1287-1287.
[5]	李桂香, 刘玲玲, 毛玉芳, 等.丁二磺酸腺苷蛋氨酸联合地塞米松对妊娠期肝内胆汁淤积症患者肝功能及血清TNF-α, IL-12水平的影响[J].现代生物医学进展, 2017, 17 (19):3765-3768.
[6]	谢幸, 苟文丽.妇产科学[M].8版.北京:人民卫生出版社, 2013:73-75.
[7]	Kawakita T, Parikh L I, Ramsey P S, et al.Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy[J].American Journal of Obstetrics & Gynecology, 2015, 213 (4):1-8. (in Chinese)
[8]	洪少妹, 洪志琴.丁二磺酸腺苷蛋氨酸治疗妊娠肝内胆汁淤积综合征临床应用效果分析[J].黑龙江医学, 2016, 40 (7):629-630.
[9]	蔡燕红.丁二磺酸腺苷蛋氨酸对妊娠期肝内胆汁淤积症患者胆汁酸、肝酶指标及妊娠期结局的影响[J].河北医药, 2017, 39 (8):1155-1157.
[10]	向华, 张笃华, 易宇凌, 等.妊娠期肝内胆汁淤积症外周血IL-12及TNF-α检测的临床意义[J].海南医学, 2016, 27 (7):1057-1059.
[11]	姚锦.妊娠肝内胆汁淤积症患者血清IFN-γ与IL-4的检测及临床意义[J].中国临床研究, 2011, 24 (3):213-214.